CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		192 Months Ended
	Oct. 31, 2011	Oct. 31, 2010	Oct. 31, 2011
Revenues, net	$ 9,931	$ 173,943	$ 5,092,064
Cost of Goods Sold	3,262	64,112	1,612,528
Gross profit	6,669	109,831	3,479,536
Operating Expenses:
Research and development	1,979,502	2,878,000	128,968,230
Research and development - related party	0	0	220,218
Selling and marketing	75,661	404,487	9,243,700
General and administrative	1,421,284	4,601,164	144,334,261
General and administrative - related party	0	0	314,328
Total Operating Expenses	3,476,447	7,883,651	283,080,737
Operating Loss	(3,469,778)	(7,773,820)	(279,601,201)
Other Income (Expense):
Miscellaneous income	0	0	686,303
Income from assets held for investment, net (Note 12)	712,075	74,330	2,840,116
Interest income	519	3,231	7,780,893
Interest expense	(34,921)	(50,540)	(68,451,078)
Change in fair value of derivative liabilities (Note 11)	3,128,459	869,532	3,493,922
Loss on extinguishment of debt	0	0	(14,134,069)
Net Income/(Loss) Before Undernoted	336,354	(6,877,267)	(347,385,113)
Minority Interest Share of Loss	0	0	3,038,185
Net income/(Loss)	336,354	(6,877,267)	(344,346,928)
Preferred Stock Dividend	0	0	3,061,474
Net Income/(Loss) Available to Common Stockholders	$ 336,354	$ (6,877,267)	$ (347,408,402)
Net Income/(Loss) Per Common Share (Note 9)
Basic (in dollars per share)	$ 0.001	$ (0.025)
Diluted (in dollars per share)	$ 0.001	$ (0.025)
Shares used in computing earnings/(loss) per share (Note 9)
Basic (in shares)	313,342,608	270,553,982
Diluted (in shares)	313,348,032	270,553,982